A supra-cellular model for coupling of bone resorption to formation during remodeling: lessons from two bone resorption inhibitors affecting bone formation differently

被引:21
作者
Jensen, Pia Rosgaard [1 ]
Andersen, Thomas Levin [1 ]
Pennypacker, Brenda L. [2 ]
Duong, Le T. [2 ]
Engelholm, Lars H. [3 ]
Delaisse, Jean-Marie [1 ]
机构
[1] Univ Southern Denmark, Inst Reg Hlth Res IRS, Vejle Lillebxlt Hosp, Clin Cell Biol KCB, DK-7100 Vejle, Denmark
[2] Merck Res Labs, Bone Biol Grp, West Point, PA 19486 USA
[3] Finsen Lab, Rigshosp, Copenhagen Bioctr, DK-2200 Copenhagen N, Denmark
关键词
Coupling; Osteoclast anabolics; Osteoprogenitors; Bone remodeling compartment canopy; Cathepsin K inhibitor; Bisphosphonates; RESORBING OSTEOCLASTS; PARATHYROID-HORMONE; CANCELLOUS BONE; CELLS; TRAFFICKING; ALENDRONATE; EXPRESSION;
D O I
10.1016/j.bbrc.2013.12.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The bone matrix is maintained functional through the combined action of bone resorbing osteoclasts and bone forming osteoblasts, in so-called bone remodeling units. The coupling of these two activities is critical for securing bone replenishment and involves osteogenic factors released by the osteoclasts. However, the osteoclasts are separated from the mature bone forming osteoblasts in time and space. Therefore the target cell of these osteoclastic factors has remained unknown. Recent explorations of the physical microenvironment of osteoclasts revealed a cell layer lining the bone marrow and forming a canopy over the whole remodeling surface, spanning from the osteoclasts to the bone forming osteoblasts. Several observations show that these canopy cells are a source of osteoblast progenitors, and we hypothesized therefore that they are the likely cells targeted by the osteogenic factors of the osteoclasts. Here we provide evidence supporting this hypothesis, by comparing the osteoclast-canopy interface in response to two types of bone resorption inhibitors in rabbit lumbar vertebrae. The bisphosphonate alendronate, an inhibitor leading to low bone formation levels, reduces the extent of canopy coverage above osteoclasts. This effect is in accordance with its toxic action on periosteoclastic cells. In contrast, odanacatib, an inhibitor preserving bone formation, increases the extent of the osteoclast-canopy interface. Interestingly, these distinct effects correlate with how fast bone formation follows resorption during these respective treatments. Furthermore, canopy cells exhibit uPARAP/Endo180, a receptor able to bind the collagen made available by osteoclasts, and reported to mediate osteoblast recruitment. Overall these observations support a mechanism where the recruitment of bone forming osteoblasts from the canopy. is induced by osteoclastic factors, thereby favoring initiation of bone formation. They lead to a model where the osteoclast-canopy interface is the physical site where coupling of bone resorption to bone formation occurs. (C) 2013 The Authors. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:694 / 699
页数:6
相关论文
共 29 条
  • [1] Abdelgawad M.E., 2013, J BONE MINER RES, V27, pS172
  • [2] Andersen T.L., AM J PATHOL IN PRESS
  • [3] Understanding Coupling between Bone Resorption and Formation Are Reversal Cells the Missing Link?
    Andersen, Thomas L.
    Abdelgawad, Mohamed E.
    Kristensen, Helene B.
    Hauge, Ellen M.
    Rolighed, Lars
    Bollerslev, Jens
    Kjaersgaard-Andersen, Per
    Delaisse, Jean-Marie
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2013, 183 (01) : 235 - 246
  • [4] A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone
    Andersen, Thomas Levin
    Sondergaard, Teis Esben
    Skorzynska, Katarzyna Ewa
    Dagnaes-Hansen, Frederik
    Plesner, Trine Lindhardt
    Hauge, Ellen Margrethe
    Plesner, Torben
    Delaisse, Jean-Marie
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (01) : 239 - 247
  • [5] ULTRASTRUCTURAL INVESTIGATIONS OF BONE RESORPTIVE CELLS IN 2 TYPES OF AUTOSOMAL-DOMINANT OSTEOPETROSIS
    BOLLERSLEV, J
    MARKS, SC
    POCKWINSE, S
    KASSEM, M
    BRIXEN, K
    STEINICHE, T
    MOSEKILDE, L
    [J]. BONE, 1993, 14 (06) : 865 - 869
  • [6] Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells
    Coxon, Fraser P.
    Thompson, Keith
    Roelofs, Anke J.
    Ebetino, F. Hal
    Rogers, Michael J.
    [J]. BONE, 2008, 42 (05) : 848 - 860
  • [7] Vesicular trafficking in osteoclasts
    Coxon, Fraser P.
    Taylor, Adam
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2008, 19 (05) : 424 - 433
  • [8] de Freitas PHL, 2009, J BONE MINER RES, V24, P1586, DOI [10.1359/JBMR.090413, 10.1359/jbmr.090413]
  • [9] Duong Le T, 2012, Bonekey Rep, V1, P67, DOI 10.1038/bonekey.2012.67
  • [10] The effects of parathyroid hormone, alendronate, or both in men with osteoporosis
    Finkelstein, JS
    Hayes, A
    Hunzelman, JL
    Wyland, JJ
    Lee, H
    Neer, RM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13) : 1216 - 1226